Latest news

See more
05 nov, 2018 Bioscience Division revenues drive operational growth to 9.6% in the third quarter and boost net profits to Euros 468 million
Read more

27 oct, 2018 Grifols AMBAR results demonstrate a significant reduction in the progression of moderate Alzheimer's Disease
Read more

22 oct, 2018 Grifols invests in ultrahigh sensitive disease diagnostic and prognostic technology
Read more

Media contacts

Journalist or media professional?

Our Media Relations team is available at:
(+34) 93 571 00 02
Restricted to media inquiries only.

Not a journalist?

For general questions and requests, please contact